跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Arexvy - SFDA Drug Approval Details
Approvals
/
SFDA
/
Arexvy
Authorized
BIOLOGICAL
Arexvy
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
64fcbb2c6f191fa8
Company
Unknown
Type
Biological
Approval Details
Approval Id
64fcbb2c6f191fa8
Drug Approval Sfda Name
Arexvy
Trade Name
Arexvy
Generic Name
Recombinant respiratory syncytial virus prefusion F protein adjuvanted with AS01E
Register Number
2802245004
Register Year
2024
Drug Type
Biological
Route Of Administration
Intramuscular use
Package Type
Vial
Package Size
1
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000002710-120-100000074032
Price
925.65
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
64fcbb2c6f191fa8
Type
Biological
Back to SFDA Approvals